|
||||||
|
Terence A. Kelly, Ph.D., Joins CoMentis as Senior Vice President for Discovery and Preclinical Development SOUTH SAN FRANCISCO, CA–(Marketwire – July 12, 2010) – CoMentis, Inc., a privately held biopharmaceutical company, today announced that Terence A. Kelly, Ph.D., has joined the company as Senior Vice President for Discovery and Preclinical Development, effective immediately. Dr. Kelly [...] NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation … SAN DIEGO—-NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which [...] Preclinical data of VB-201 to be presented at EULAR Annual European Congress of Rheumatology VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the upcoming presentation of preclinical data from the company’s lead program, VB-201, at the European League Against Rheumatism Annual European Congress [...] |
 |
|||||
|
Copyright © 2012 PSORIASIS TREATMENT - All Rights Reserved |
||||||
Recent Comments